Finding Resilience With Migraine, Its Comorbidities, and COVID
You are currently watching a preview of this interview. Unlock the full version by upgrading to an Access Pass bundle! Get FREE access to 8 expert interviews from Day 1 and Day 2 when you register today!
Key Questions
- Is there a correlation between migraine and mood disorders, like depression and anxiety? Do people have depression and anxiety because of migraine?
- Why is it important to treat depression in people with migraine?
- In the course of treating migraine, when should mood disorders be assessed and treated?
- Are there treatments that can target both migraine and depression?
- Is nighttime jaw clenching connected to anxiety, and can it trigger migraine attacks?
- How does parental migraine impact adolescent children?
- Do people with chronic migraine experience personality changes?
- How might we minimize migraine attacks when dealing with stress, such as the stress of a pandemic?
- What are some coping strategies that can help with the loss and fear that can accompany migraine?
- How can we continue to build up our resilience when faced with migraine disease, especially when it’s chronic?
Interview Notes
- Expert opinion: migraine, psychiatric comorbidities, and treatment
- When mom has migraine: An observational study of the impact of parental migraine on adolescent children
- The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) study methods and baseline results.
- Dr. Rosen on Twitter: @NoheadachesNoah
- Dr. Rosen at Northwell Health
Noah Rosen, MD, FAHS
Associate Professor of Neurology & Psychiatry
Zucker School of Medicine at Hofstra/Northwell
Noah Rosen, M.D., FAHS, has been a headache specialist for over a dozen years. He is board certified in four areas: neurology, psychiatry, pain management, and headache medicine. He is an associate professor of neurology and psychiatry at the Zucker School of Medicine at Hofstra/Northwell, and adjunct clinical assistant professor of neurology at Albert Einstein College of Medicine. He also serves as residency training director of neurology at Northwell Health in Great Neck, N.Y., and sees patients at the Headache Center at Northwell Health Institute for Neurology and Neurosurgery. Previously he served as fellowship director for headache medicine at Thomas Jefferson University. Dr. Rosen’s major research interests are in headache comorbidities including psychiatric and psychological issues, access to subspecialist care, and validating educational activities. He has additional interests in using technology to improve health care outcomes and empower consumers’ self-determination.
Purchase full access to the entire 2024 Summit. Includes:
- All expert interviews with separate audio (MP3) files & transcripts
- Lifetime on-demand access with no annual fee to 2024 Summit
- Interview Summaries
- Treatment Guidelines
- And much more!
Related Talks for: Day 1 (2021)
Why Doesn’t Migraine Have a Cure Yet?
Tissa Wijeratne, MD, FRACP, FAAN
Unlocking the Mystery of Migraine Pathogenesis
Peter Goadsby, MD, PhD, FRS
Latest Strategies for Chronic Migraine Control
Carrie Dougherty, MD, FAHS
The Coalition For Headache And Migraine Patients (CHAMP) is an organization that provides support to people with headache, migraine and cluster diseases who are often stigmatized and under-served.
CHAMP brings together organizations and leaders in this disease area to enhance communication, coordination and collaboration to more effectively help people wherever they are on their patient journey.
CHAMP is working to identify unmet needs of those with headache, migraine and cluster diseases, and will work to better support patients and their caregivers.
Eli Lilly and Company is proud to sponsor the Migraine World Summit.
Listen in as world-leading migraine and headache experts share their gratitude for the 60+ patient advocates who help produce the Summit each year.
